YAP‐TEAD mediates PPAR α–induced hepatomegaly and liver regeneration in mice
Authors:
- 13 August 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 75 (1) , 74-88
Abstract
Background and Aims: Peroxisome proliferator–activated receptor α (PPARα, NR1C1) is a ligand‐activated nuclear receptor involved in the regulation of lipid catabolism and energy homeostasis. PPARα activation induces hepatomegaly and plays an important role in liver regeneration, but the underlying mechanisms remain unclear. Approach and Results: In this study, the effect of PPARα activation on liver enlargement and regeneration was investigated in several strains of genetically modified mice. PPARα activation by the specific agonist WY‐14643 significantly induced hepatomegaly and accelerated liver regeneration after 70% partial hepatectomy (PHx) in wild‐type mice and Ppara fl/fl mice, while these effects were abolished in hepatocyte‐specific Ppara‐deficient (Ppara ΔHep) mice. Moreover, PPARα activation promoted hepatocyte hypertrophy around the central vein area and hepatocyte proliferation around the portal vein area. Mechanistically, PPARα activation regulated expression of yes‐associated protein (YAP) and its downstream targets (connective tissue growth factor, cysteine‐rich angiogenic inducer 61, and ankyrin repeat domain 1) as well as proliferation‐related proteins (cyclins A1, D1, and E1). Binding of YAP with the PPARα E domain was critical for the interaction between YAP and PPARα. PPARα activation further induced nuclear translocation of YAP. Disruption of the YAP–transcriptional enhancer factor domain family member (TEAD) association significantly suppressed PPARα‐induced hepatomegaly and hepatocyte enlargement and proliferation. In addition, PPARα failed to induce hepatomegaly in adeno‐associated virus–Yap short hairpin RNA–treated mice and liver‐specific Yap‐deficient mice. Blockade of YAP signaling abolished PPARα‐induced hepatocyte hypertrophy around the central vein area and hepatocyte proliferation around the portal vein area. Conclusions: This study revealed a function of PPARα in regulating liver size and liver regeneration through activation of the YAP–TEAD signaling pathway. These findings have implications for understanding the physiological functions of PPARα and suggest its potential for manipulation of liver size and liver regeneration.Keywords
Funding Information
- National Natural Science Foundation of China (81730103, 81973392, 82020108031, 82025034)
This publication has 50 references indexed in Scilit:
- Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAPGenes & Development, 2012
- Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in miceHepatology, 2011
- PPARα-Dependent Activation of Cell Cycle Control and DNA Repair Genes in Hepatic Nonparenchymal CellsToxicological Sciences, 2010
- TEAD mediates YAP-dependent gene induction and growth controlGenes & Development, 2008
- Elucidation of a Universal Size-Control Mechanism in Drosophila and MammalsCell, 2007
- The PPARα-Humanized Mouse: A Model to Investigate Species Differences in Liver Toxicity Mediated by PPARαToxicological Sciences, 2007
- Hepatocyte-restricted constitutive activation of PPAR induces hepatoproliferation but not hepatocarcinogenesisCarcinogenesis, 2007
- Sorting out the roles of PPAR in energy metabolism and vascular homeostasisJournal of Clinical Investigation, 2006
- Diminished Hepatocellular Proliferation in Mice Humanized for the Nuclear Receptor Peroxisome Proliferator-Activated Receptor αCancer Research, 2004
- Delayed liver regeneration in peroxisome proliferator-activated receptor-α-null miceHepatology, 2002